Form 8-K - Current report:
SEC Accession No. 0001493152-25-027541
Filing Date
2025-12-12
Accepted
2025-12-12 17:10:38
Documents
18
Period of Report
2025-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 68360
2 EX-4.1 ex4-1.htm EX-4.1 134771
3 EX-4.2 ex4-2.htm EX-4.2 134697
4 EX-4.3 ex4-3.htm EX-4.3 134409
5 EX-10.1 ex10-1.htm EX-10.1 64832
6 EX-99.1 ex99-1.htm EX-99.1 16908
7 EX-99.2 ex99-2.htm EX-99.2 15838
  Complete submission text file 0001493152-25-027541.txt   854261

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE envb-20251211.xsd EX-101.SCH 3011
9 XBRL LABEL FILE envb-20251211_lab.xml EX-101.LAB 34239
10 XBRL PRESENTATION FILE envb-20251211_pre.xml EX-101.PRE 22356
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3841
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 (617) 444-8400
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 251569070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)